Diederich Sven, Franzen Norma-Fiona, Bähr Volker, Oelkers Wolfgang
Division of Endocrinology and Diabetes, Klinikum Benjamin Franklin, Freie Universität Berlin, Hindenburgdamm 3012200 Berlin, Germany.
Eur J Endocrinol. 2003 Jun;148(6):609-17. doi: 10.1530/eje.0.1480609.
Severe hyponatremia due to hypopituitarism and adrenal insufficiency can be life-threatening, and treatment with glucocorticoids is very effective once the diagnosis of the underlying disorder has been made. In our experience, the diagnosis of hypopituitarism in hyponatremic patients is often overlooked.
In a retrospective study we screened the files of 185 patients with severe hyponatremia (<130 mmol/l) that had been seen in one endocrinological unit of a university hospital between 1981 and 2001 in order to describe the clinical spectrum of patients with hyponatremia and hypopituitarism including secondary adrenal insufficiency.
In 139 cases it was possible to clearly ascribe the patients to the pathophysiological groups of (i) primary sodium deficiency, (ii) edematous disorders, and (iii) normovolemic disorders including the "syndrome of inappropriate secretion of antidiuretic hormone" (SIADH). Twenty-eight patients with severe "normovolemic hyponatremia" (serum sodium: 116+/-7 mmol/l, mean+/-s.d.) had hypopituitarism and secondary adrenal insufficiency as shown by basal cortisol measurements and dynamic tests of adrenal function. In 25 cases of this group hypopituitarism (mostly due to empty sella, Sheehan's syndrome and pituitary tumors) had not been recognized previously, and in 12 cases recurrent hyponatremia during previous hospital admissions (up to four times) could be documented. The mean age of these patients (21 women, seven men) was 68 Years. The most frequently occurring clinical signs were missing or scanty pubic and axillary hair, pale and doughy skin, and small testicles in the men. Frequent symptoms like nausea and vomiting, confusion, disorientation, somnolence or coma were similar to those in 91 patients with SIADH. Basal serum cortisol levels in the acutely ill state ranged from 20 to 439 nmol/l (mean+/-s.d.: 157+/-123), while in 30 other severely hyponatremic patients it ranged from 274 to 1732 nmol/l (732+/-351 nmol/l). In most patients with hyponatremic hypopituitarism, plasma antidiuretic hormone levels were inappropriately high, probably due to a failure of endogenous cortisol to suppress the hormone in a stressful situation. All patients recovered after low-dose hydrocortisone substitution. Most patients had other pituitary hormone deficiencies and were appropriately substituted subsequently.
Hypopituitarism including secondary adrenal insufficiency seems to be a frequently overlooked cause of severe hyponatremia. A high level of suspicion is the best way to recognize the underlying disorder. Treatment with hydrocortisone is very effective.
垂体功能减退症和肾上腺功能不全所致的严重低钠血症可能危及生命,一旦确诊潜在疾病,使用糖皮质激素治疗非常有效。根据我们的经验,低钠血症患者的垂体功能减退症诊断常常被忽视。
在一项回顾性研究中,我们筛查了1981年至2001年间在一所大学医院的一个内分泌科就诊的185例严重低钠血症(<130 mmol/l)患者的病历,以描述低钠血症和垂体功能减退症患者(包括继发性肾上腺功能不全)的临床谱。
在139例病例中,可以明确将患者归为以下病理生理组:(i)原发性钠缺乏,(ii)水肿性疾病,以及(iii)血容量正常的疾病,包括“抗利尿激素分泌不当综合征”(SIADH)。28例严重“血容量正常性低钠血症”患者(血清钠:116±7 mmol/l,均值±标准差)存在垂体功能减退症和继发性肾上腺功能不全,基础皮质醇测量和肾上腺功能动态试验显示了这一点。在该组的25例病例中,垂体功能减退症(主要由于空蝶鞍、席汉综合征和垂体肿瘤)此前未被识别,并且在12例病例中,可以记录到既往住院期间反复出现低钠血症(多达4次)。这些患者(21名女性,7名男性)的平均年龄为68岁。最常见的临床体征是阴毛和腋毛缺失或稀少、皮肤苍白且呈面团样,男性患者睾丸较小。恶心、呕吐、意识模糊、定向障碍、嗜睡或昏迷等常见症状与91例SIADH患者相似。急性病状态下的基础血清皮质醇水平范围为20至439 nmol/l(均值±标准差:157±123),而在其他30例严重低钠血症患者中,该范围为274至1732 nmol/l(732±351 nmol/l)。在大多数低钠血症性垂体功能减退症患者中,血浆抗利尿激素水平异常升高,这可能是由于内源性皮质醇在应激状态下未能抑制该激素所致。所有患者在小剂量氢化可的松替代治疗后均康复。大多数患者还存在其他垂体激素缺乏,随后进行了适当的替代治疗。
包括继发性肾上腺功能不全在内的垂体功能减退症似乎是严重低钠血症的一个经常被忽视的原因。高度怀疑是识别潜在疾病的最佳方法。氢化可的松治疗非常有效。